• KO-Validated
Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Homo sapiens (Human) Polyclonal antibody

DJ1; Autosomal Recessive,Early Onset

  • Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Packages (Simulation)
  • Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Packages (Simulation)
  • Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Used in DAB staining on fromalin fixed paraffin-embedded Kidney tissue
  • PAL059Hu01.jpg WB Image
  • Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Western Blot; Sample: Human Jurkat cell lysate;
    Primary Ab: 2µg/ml Rabbit Anti-Human PARK7 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Knockout Varification:
    Lane 1: Wild-type Jurkat cell lysate;
    Lane 2: PARK7 knockout Jurkat cell lysate;
    Predicted MW: 20kd
    Observed MW: 22kd
    Primary Ab: 2µg/ml Rabbit Anti-Human PARK7 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Western Blot; Sample: Human Liver lysate;
    Primary Ab: 2µg/ml Rabbit Anti-Human PARK7 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Western Blot; Sample: Rat Liver lysate;
    Primary Ab: 2µg/ml Rabbit Anti-Human PARK7 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) Western Blot; Sample: Rat Heart lysate;
    Primary Ab: 2µg/ml Rabbit Anti-Human PARK7 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against PARK7. It has been selected for its ability to recognize PARK7 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Recommend products